Overview

Trial of JYB1904 in Chronic Spontaneous Urticaria.

Status:
RECRUITING
Trial end date:
2026-07-15
Target enrollment:
Participant gender:
Summary
This Phase II Trial is Meant to Evaluate the Efficacy, Safety and Tolerability of JYB1904 Injection in Patients With Chronic Spontaneous Urticaria.
Phase:
PHASE2
Details
Lead Sponsor:
Jemincare
Treatments:
Omalizumab